Read the updated advice - Association of Paediatric Anaesthetists
... Opioids may be required for second line analgesia in cases where the combination of paracetamol and a NSAID are inadequate. This can represent a problem in that dosing after discharge may not be foll ...
... Opioids may be required for second line analgesia in cases where the combination of paracetamol and a NSAID are inadequate. This can represent a problem in that dosing after discharge may not be foll ...
Restoril (temazepam)
... department for observation and treatment. The prescription bottle of medication (and any other medication suspected in the overdose) should be brought as well, because the information on the prescription label can be helpful to the treating physician in determining the number of pills ingested. ...
... department for observation and treatment. The prescription bottle of medication (and any other medication suspected in the overdose) should be brought as well, because the information on the prescription label can be helpful to the treating physician in determining the number of pills ingested. ...
Ketorolac Tromethamine 10 mg Tablet
... It is indicated for the short-term management of moderate to severe acute postoperative pain. DOSAGE & ADMINISTRATION Recommended dose is 10 mg every 4-6 hours. It should be used short-term only (up to 7 days) and are not recommended for chronic use. Doses exceeding 40 mg/day is not recommended. SID ...
... It is indicated for the short-term management of moderate to severe acute postoperative pain. DOSAGE & ADMINISTRATION Recommended dose is 10 mg every 4-6 hours. It should be used short-term only (up to 7 days) and are not recommended for chronic use. Doses exceeding 40 mg/day is not recommended. SID ...
Minolac - ACI Limited
... Minolac® is indicated for the management of moderate to severe acute pain (usually in a severe acute post-operative pain, dental pain, cancer pain, gynecological pain, acute traumatic pain and migraine also). Dosage and administration Oral: Adult: The recommended oral dose of Minolac® is 10mg every ...
... Minolac® is indicated for the management of moderate to severe acute pain (usually in a severe acute post-operative pain, dental pain, cancer pain, gynecological pain, acute traumatic pain and migraine also). Dosage and administration Oral: Adult: The recommended oral dose of Minolac® is 10mg every ...
Paracetamol self poisoning_ahd (Specific toxin)
... By what mechanism does paracetamol cause problems in overdose? Why does the body produce “toxic metabolites” How can you estimate her risk of hepatic damage? What is the relevance of alcohol ingestion to the risk of hepatotoxicity? ...
... By what mechanism does paracetamol cause problems in overdose? Why does the body produce “toxic metabolites” How can you estimate her risk of hepatic damage? What is the relevance of alcohol ingestion to the risk of hepatotoxicity? ...
CM 21- Stimulants, Benzo, Barbs, Opiates, Heroin Psychostimulants
... Imodium 4 mg Q4 hours prn diarrhea Seroquel 25 mg-800 mg Q6 hours prn craving o 5HT2A, 5HT2C, 5HT1A Suboxone Suboxone is a combination of: o Buprenorphine = partial opiate agonist o Naloxone (opiate blocker to prevent IV use) Subxone has potential for abuse and produces dependence of the opi ...
... Imodium 4 mg Q4 hours prn diarrhea Seroquel 25 mg-800 mg Q6 hours prn craving o 5HT2A, 5HT2C, 5HT1A Suboxone Suboxone is a combination of: o Buprenorphine = partial opiate agonist o Naloxone (opiate blocker to prevent IV use) Subxone has potential for abuse and produces dependence of the opi ...
here - Southport Animal Hospital
... Isoflurane- is an inhalant anesthetic. It is well tolerated in debilitated patients and those with hepatic or renal impairment. Adverse and Common Side Effects- dose-dependant cardiac and respiratory depression occurs. Hypotension, respiratory depression, arrhythmias, nausea, vomiting and post opera ...
... Isoflurane- is an inhalant anesthetic. It is well tolerated in debilitated patients and those with hepatic or renal impairment. Adverse and Common Side Effects- dose-dependant cardiac and respiratory depression occurs. Hypotension, respiratory depression, arrhythmias, nausea, vomiting and post opera ...
Anti-depressants
... Unique structure. Low cardiotoxicity, few anticholinergic side effects. Drowsiness +. Nausea. 150 mg /day. ...
... Unique structure. Low cardiotoxicity, few anticholinergic side effects. Drowsiness +. Nausea. 150 mg /day. ...
potentially inappropriate medications
... Most potent negative inotrope and may induce heart failure. These products produce CNS side effects. Common CNS side effects and potential for drug-drug interactions. Diarrhea and leuko These antidepressants have strong anticholinergic and sedating properties and are rarely the antidepressant of cho ...
... Most potent negative inotrope and may induce heart failure. These products produce CNS side effects. Common CNS side effects and potential for drug-drug interactions. Diarrhea and leuko These antidepressants have strong anticholinergic and sedating properties and are rarely the antidepressant of cho ...
Opioid Facts
... Opioids are commonly prescribed because of their effective analgesic, or pain-relieving, properties. Studies have shown that properly managed medical use of opioid analgesic compounds (taken exactly as prescribed) is safe, can manage pain effectively, and rarely causes addiction. Among the compounds ...
... Opioids are commonly prescribed because of their effective analgesic, or pain-relieving, properties. Studies have shown that properly managed medical use of opioid analgesic compounds (taken exactly as prescribed) is safe, can manage pain effectively, and rarely causes addiction. Among the compounds ...
Opiate receptors, endogenous opioid systems in brain, Analgesia
... Opioid withdrawal - abstinence syndrome Severity depends on dose used and rate of elimination. Rhinorrhea Lacrimation Chills Goose flesh - ‘cold turkey’ Muscle aches Diarrhea Yawning Anxiety Hostility Hyperalgesia Precipitated withdrawal by a partial agonist or antagonist administration ...
... Opioid withdrawal - abstinence syndrome Severity depends on dose used and rate of elimination. Rhinorrhea Lacrimation Chills Goose flesh - ‘cold turkey’ Muscle aches Diarrhea Yawning Anxiety Hostility Hyperalgesia Precipitated withdrawal by a partial agonist or antagonist administration ...
Stadol Nasal Spray (butorphanol tartrate)
... The initial dose sequence outlined above may be repeated in 3-4 hours as required after the second dose of the sequence. For the management of severe pain, an initial dose of 2mg (1 spray in each nostril) may be used in patients who will be able to remain recumbent in the event drowsiness or dizzine ...
... The initial dose sequence outlined above may be repeated in 3-4 hours as required after the second dose of the sequence. For the management of severe pain, an initial dose of 2mg (1 spray in each nostril) may be used in patients who will be able to remain recumbent in the event drowsiness or dizzine ...
ProSom (estazolam)
... ProSom (estazolam) is a benzodiazepine sedative-hypnotic medication approved for short-term treatment of insomnia. Similar to other benzodiazepines, ProSom has anxiolytic effects (i.e., relieves anxiety), but it is seldom prescribed for this use. It has an intermediate duration of action (i.e., half ...
... ProSom (estazolam) is a benzodiazepine sedative-hypnotic medication approved for short-term treatment of insomnia. Similar to other benzodiazepines, ProSom has anxiolytic effects (i.e., relieves anxiety), but it is seldom prescribed for this use. It has an intermediate duration of action (i.e., half ...
OPIOIDS
... given to 2 groups of patients: – post-surgery patients receive it on short-term basis – cancer and burn victims given it for much longer durations (typically given IM or under the skin) ...
... given to 2 groups of patients: – post-surgery patients receive it on short-term basis – cancer and burn victims given it for much longer durations (typically given IM or under the skin) ...
Opioid Anelgesics
... – Changes in cellular adaptive responses but not receptor numbers – Tolerance is marked for CNS actions such as analgesia, euphoria, respiratory depression ...
... – Changes in cellular adaptive responses but not receptor numbers – Tolerance is marked for CNS actions such as analgesia, euphoria, respiratory depression ...
Patient Information Sheet YOUR PRESCRIPTION FOR BALACET
... subsequent increased dose of 0.1 mg/kg body weight may be administered. If an IV route of administration is not available, naloxone may be administered IM or subcutaneously in divided doses. If necessary, naloxone can be diluted with Sterile Water for injection. Blood gases, pH, and electrolytes sho ...
... subsequent increased dose of 0.1 mg/kg body weight may be administered. If an IV route of administration is not available, naloxone may be administered IM or subcutaneously in divided doses. If necessary, naloxone can be diluted with Sterile Water for injection. Blood gases, pH, and electrolytes sho ...
Medication Alternatives for the Elderly
... This material was prepared by HealthInsight, the Medicare Quality Improvement Organization for Nevada and Utah, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS ...
... This material was prepared by HealthInsight, the Medicare Quality Improvement Organization for Nevada and Utah, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS ...
Medication Alternatives for the Elderly
... This material was prepared by Quality Insights of Pennsylvania, the Medicare Quality Improvement Organization for Pennsylvania, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessa ...
... This material was prepared by Quality Insights of Pennsylvania, the Medicare Quality Improvement Organization for Pennsylvania, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessa ...
OPIOIDS
... Where do they come from? – poppy plant: from middle east and Asia – dried sap from plant is opium; cultivated annually BUT ...
... Where do they come from? – poppy plant: from middle east and Asia – dried sap from plant is opium; cultivated annually BUT ...
drugs of abuse
... • Prescription meds- mostly benzodiazepines • Codeine containing medications eg Paracodeine and cough mixtures. ...
... • Prescription meds- mostly benzodiazepines • Codeine containing medications eg Paracodeine and cough mixtures. ...
OPIOIDS
... • Stoppage (or reduction] in opioid use that has been heavy and prolonged (several weeks +) • OR administration of opioid antagonist after period of use • Symptoms include: (need at least 3 for DSM criteria) ...
... • Stoppage (or reduction] in opioid use that has been heavy and prolonged (several weeks +) • OR administration of opioid antagonist after period of use • Symptoms include: (need at least 3 for DSM criteria) ...
... Promethazine, not controlled under Chapter 90, common trade name “Phenergan”, used for antianti-nausea, has a strong sedating effect. Propoxyphene 2 optical isomer forms (dextropropoxyphene and levopropoxyphene) Cannot differentiate isomer forms once in ingested Dextropropoxyphene, Schedule IV, comm ...
Opioids
... Long Duration of Action: very slow dissociation from receptor (resistance to naloxone ...
... Long Duration of Action: very slow dissociation from receptor (resistance to naloxone ...
View PowerPoint
... 1. Gradual dosage reduction - individual withdrawal rate - adjuvant drugs 2. Psychological support - simple encouragement to psychological therapies - long term - information - motivation ...
... 1. Gradual dosage reduction - individual withdrawal rate - adjuvant drugs 2. Psychological support - simple encouragement to psychological therapies - long term - information - motivation ...
Dextropropoxyphene
Dextropropoxyphene is an analgesic in the opioid category, patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive (cough suppressant) and local anaesthetic effects. The drug has been taken off the market in Europe and the US due to concerns of fatal overdoses and heart arrhythmias. Its onset of analgesia (pain relief) is said to be 20–30 minutes and peak effects are seen about 1.5–2 hours after oral administration.Dextropropoxyphene is sometimes combined with acetaminophen or aspirin. Trade names include Darvocet-N and Di-Gesic, Darvon with APAP (for dextropropoxyphene and paracetamol) and Darvon with ASA (for dextropropoxyphene and aspirin). The British approved name (i.e. the generic name of the active ingredient) of the paracetamol/dextropropoxyphene preparation is ""co-proxamol"" (sold under a variety of brand names); however, it has been withdrawn since 2007, and is no longer available to new patients, with exceptions. The paracetamol combination(s) are known as Capadex or Di-Gesic in Australia, Lentogesic in South Africa, and Di-Antalvic in France (unlike co-proxamol, which is an approved name, these are all brand names).Dextropropoxyphene is known under several synonyms, including: Alpha-d-4-dimethylamino-3-methyl-1,2-diphenyl-2-butanol propionate [(2S,3S)-4-(Dimethylamino)-3- methyl-1,2-diphenylbutan-2-yl] propanoate (+)-1,2-Diphenyl-2-propionoxy- 3-methyl-4-di-methylaminobutane Desoxypropiophen↑ 1.0 1.1 1.2 1.3 1.4 ↑ ↑ ↑ ↑ ↑ ↑ ↑